Verdiva Bio Limited
Drug Discovery
- [email protected]
- Website
- https://verdivabio.com/
- Membership category
- Corporate
25 Austen Road, Guildford, Surrey, GU1 3NP, United Kingdom
Verdiva Bio Limited at a glance
About Verdiva Bio Limited
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
The Verdiva team will harness the emerging science in gut-brain biology and leverage their history of successful drug development to advance novel therapeutic options to transform the lives of millions.
Verdiva’s most advanced therapy in development is VRB-101, an oral GLP-1 peptide that has demonstrated compelling efficacy potential in a phase 1 study, which also confirmed the viability of once-weekly dosing.
The company’s portfolio includes multiple amylin molecules (oral and subcutaneous agonists) and other undisclosed programs that offer the potential for enhanced efficacy, improved tolerability, and healthier weight loss.
